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Solvent responsive catalyst improves NMR sensitivity via efficient 
magnetisation transfer 
Amy J. Ruddlesden and Simon B. Duckett
*
A bidentate iridium carbene complex, Ir(κC,O-L1)(COD), has been 
synthesised which contains a strongly electron donating carbene ligand 
that is functionalised by a cis-spanning phenolate group. This complex acts 
as a precursor to effective magnetisation transfer catalysts which form 
after reaction with H2 and a suitable two electron donor. In solvents such 
as benzene, containing pyridine, they are exemplified by neutral, chiral 
Ir(H)2(κC,O-L1)(py)2 with inequivalent hydride ligands and Ir-O bond 
retention, whilst in methanol, Ir-O bond cleavage leads to zwitterionic 
[Ir(H)2(κC,O
−
-L1)(py)3]
+
, with chemically equivalent hydride ligands. The 
active catalyst’s form is therefore solvent dependent. Both these 
complexes break the magnetic symmetry of the hydride ligands and are 
active in the catalytic transfer of polarisation from parahydrogen to a 
loosely bound ligand. Test results on pyridine, nicotinaldehyde and 
nicotine reveal up to ≈ 1.2 % single spin proton polarisation levels in their 
1
H signals which compare to the normal 0.003% level at 9.4 Tesla. These 
results exemplify how rational catalyst design yields a solvent dependent 
catalyst with good SABRE activity. 
 The use of hyperpolarisation methods to overcome the 
inherent insensitivity of NMR spectroscopy reflects an area of 
research where Parahydrogen Induced Polarisation (PHIP) 
features heavily.
1
 The incorporation of parahydrogen (p-H2), a 
nuclear singlet, into a molecule was first shown to produce an 
enhanced NMR signal in 1987.
2
  The increase in signal intensity 
for resonances arising from, or coupled to, p-H2 derived 
protons, has since been the subject of intense investigation. 
Recently a p-H2 technique that does not chemically change a 
molecule, called Signal Amplification By Reversible Exchange 
(SABRE), has been developed.
3
 Polarisation is transferred 
through J-coupling between the p-H2 derived hydride ligands 
and the substrate ligands.
3
 Exchange with free substrate and 
fresh p-H2 enables the build-up of polarisation in the substrate 
pool through multiple visits to the catalyst. The most 
commonly used catalysts are cationic species which contain 
either phosphine
4-5
 or N-heterocyclic carbene (NHC) ligands.
6-7
  
 In fact, one of the most effective magnetisation transfer 
catalysts is Ir(COD)(IMes)Cl
7
 [where IMes = 1,3-bis(2,4,6-
trimethylphenyl) imidazole-2-ylidene, COD = cyclooctadiene] 
which forms the charged complex, [Ir(H)2(IMes)(substrate)3]Cl 
once activated with H2 and a substrate. This SABRE catalyst 
contains chemically equivalent but magnetically inequivalent 
hydride ligands and polarisation transfer has proven 
particularly efficient in polar protic solvents such as methanol. 
Furthermore, using this catalyst a wide range of substrates 
including nicotinamide,
8-10
 isoniazid
11
 and pyrazole
12
 have 
been shown to become hyperpolarised. This type of approach 
has been exemplified for 
1
H, 
13
C, 
31
P, 
19
F and 
15
N nuclei.
5,13-15
  
However, due to the charged nature of such a species, it has 
proven less efficient in the range of low polarity solvents 
commonly used in NMR analysis. 
 It has also been shown that species with chemically 
inequivalent hydride ligands can act as SABRE catalysts. One 
reported example of this class of catalyst is given by 
[Ir(H)2(CH3CN)(IMes)(PCy3)(pyridine)]Cl.
16
 Recently, a system 
that exhibits a wider solvent tolerance has been developed. It 
contains a bidentate ligand which binds through carbene and 
phenolate centres, resulting in a neutral catalyst in all solvents 
tested. While it was found to exhibit greater activity in non-
polar solvents such as benzene,
17
 it was not efficient in 
methanol due to much slower ligand exchange. 
 In this study, the related neutral iridium complex, Ir(κC,O-
L1)(COD), 1, [where L1 = 3-(2-methylene-phenolate)-1-(2,4,6-
trimethylphenyl)imidazolylidene], has been synthesised 
starting from salicylaldehyde. It contains a cis-spanning 
phenolate-substituted bidentate NHC (see Scheme 1). Benzyl 
protection of the phenol
18
 allowed conversion of the aldehyde 
to the bromide
19
 via the alcohol.
20
 Addition of 1-(2,4,6-
trimethylphenyl)-1H-imidazole then formed the imidazolium 
bromide salt.
21
 Deprotection followed by silver carbene 
formation and subsequent transmetallation
22
 afforded the 
product, the phenoxide iridium carbene complex, 1. Key 
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compounds have been characterised by NMR and MS as 
illustrated in the ESI. 
O
OH
O
OBn
OH
OBn
Reagents and conditions:
(i) Acetone, K2CO3, BnBr, reflux, 2 h; (ii) NaBH4, MeOH, 0 °C then r.t., 30 min; 
(iii) PBr3, DCM, r.t., 2 h; (iv) 1-(2,4,6-trimethylphenyl)-1H-imidazole, toluene, reflux, 18 h;
(v) MeOH, Pd(OH)2/C, H2, r.t., 20 h then 60 °C, 6 h; (vi) Ag2O, DCM, r.t., 16 h; 
(vii) [Ir(COD)Cl]2, THF, DCM, r.t., 4 h
(i) (ii) (iii)
Br
OBn
N
N
BnO
Br
N N
O
Ag
(iv) (v)
NN
Ir O
(vi)
N
N
HO
Br
(vii)
90 % 99 % 100 %
97 % 100 %
63 % 40 %
1
 
Scheme 1. Synthetic route to 1. 
 In solution, complex 1 appears yellow/orange in colour. 
UV-Vis analysis in DCM showed it exhibits three absorption 
bands in the visible region of the spectrum (373, 425 and 490 
nm) with absorption coefficients in the range of charge 
transfer transitions (1017, 1326 and 249 dm
3
 mol
−1
 cm
−1
). 
Work by Perutz et al.
23-26
 has assigned similar bands in related 
square planar metal complexes to metal d-p transitions 
although earlier assignments suggested they were metal-to-
ligand charge transfer bands.
27-29
 
 At room temperature, the 
1
H NMR spectrum of complex 1 
in CD2Cl2 yields well resolved resonances (see Figure 1). Two 
doublets at δ 6.53 and 5.17 are observed for the CH2 linker 
protons which have a common 
2
J(HH) coupling of 14.9 Hz. 
These two protons are diastereotopic due to the seven-
membered metallocycle which is indicative of the retention of 
the Ir-O bond.
30
 Complex 1 is air/moisture sensitive but stable 
as a solid and in solution under N2. It also forms stable 
complexes once fully reacted with substrate and hydrogen as 
detailed in the following reactions. 
 
Figure 1. 
1
H NMR spectrum of 1 showing evidence for the diastereotopic CH2 linker 
protons with key CH resonances labelled. 
 Upon cooling a CD2Cl2 solution of complex 1 to 243 K all of 
its NMR signals become broad and undefined due to fluxional 
behaviour and when pyridine is added to this solution no 
reaction is evident. If, however, H2 gas is added at 255 K, a 
limited reaction occurs as two pairs of hydride signals are now 
seen at δ −12.35 and −18.25 (1.7 % conversion) and at δ 
−12.39 and −17.64 (0.6 %). These minor hydride containing 
products are conformational isomers of compound 2 (see 
Scheme 3) which arise due to differing metallocycle 
orientations;
30
 analogous behaviour has been reported.
17
 
 When p-H2 is used in this reaction, these hydride ligand 
signals do not show any significant 
1
H NMR signal 
enhancement. However, the free H2 signal in these spectra is 
substantial which suggests that 1 undergoes rapid and 
reversible oxidative addition of H2 to form 2 which consumes 
the p-H2. There is no indication of the hydrogenation of COD at 
255 K and upon warming to 298 K, these hydride signals 
broaden into the baseline of the corresponding NMR spectra 
and strong signals for 1 are always visible. 
 When a CD2Cl2 solution of 1 reacts with both pyridine and 
H2 at 298 K a new neutral iridium species, Ir(H)2(κC,O-L1)(py)2, 
3 is observed to slowly form containing two bound pyridine 
environments in a ratio of 1:1 (see ESI for details). This species 
is also formed in C6D6. The mutually coupled inequivalent 
hydride signals appear in CD2Cl2 at δ −22.55 and −25.49 (
2
J(HH) 
= 8.1 Hz) and in C6D6 at δ −21.94 and −24.52 (
2
J(HH) = 7.7 Hz). 
Their inequivalence suggests Ir-O bond retention, a fact which 
is further supported by the diastereotopic nature of the CH2 
linker protons which appear as doublets in both CD2Cl2 and 
C6D6. Both complexes undergo pyridine and H2 exchange as 
highlighted in Scheme 2, although only the pyridine ligand 
trans to hydride dissociates. The use of EXSY NMR
31
 
experiments enabled determination of experimental rate 
constants for pyridine loss in 3 at 294 K of 3.74 ± 0.06 s
−1
 in 
CD2Cl2 and 13.5 ± 0.6 s
−1
 in C6D6. The corresponding H2 loss 
rates were 0.80 ± 0.01 s
−1
 and 3.02 ± 0.07 s
−1
 respectively and 
are therefore much slower than those of pyridine loss.  
Ir
py
O
H
H
py
py = pyridine
Ir
py
O
H
H
py
Catalytic transfer
of magnetisation
Ligand
exchange
Free pyridine with strong magnetic signal
 
Scheme 2. Transfer of hydride polarisation into the indicated pyridine ligand is followed 
by ligand exchange to build-up hyperpolarised pyridine in solution.   
 This behaviour changes significantly upon moving to protic 
methanol. Now, the addition of H2 to a CD3OD solution of 
complex 1 at 250 K, results in a very limited reaction to form a 
dihydride (< 1 %, with resonances at δ −12.65 and −18.27 and 
the low concentration presumably prevents observation of its 
conformational isomer) but upon warming further, rapid and 
total decomposition of 1 follows. In contrast, the addition of 
pyridine to a CD3OD solution of complex 1 at 243 K forms the 
phenolate dissociation product, square planar 4 quantitatively 
(see Scheme 3 and ESI) where the COD ligand yields four 
inequivalent alkene proton resonances.  
 Upon the addition of p-H2 and pyridine to 4 at 243 K, two 
PHIP enhanced hydride signals become immediately visible at 
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δ −12.34 and −17.50 that are shown to couple via COSY. They 
arise from H2 addition to 4 which initially forms the alkene 
dihydride complex, 5. The CH2 linker protons of 5 remain 
diastereotopic on phenolate rotation due to the absence of a 
mirror  plane. Upon warming to 265 K, this system evolves 
further and a single hydride signal becomes visible at δ −22.18 
due to the formation of [Ir(H)2(κC,O
−
-L1)(py)3]
+
, 6; the COD is 
converted to cyclooctene. Further NMR analysis, confirms that 
6 contains two bound pyridine ligand environments, in a 2:1 
ratio, two hydride ligands and an iridium-carbene bond. Its CH2 
linker protons are now equivalent, appearing as a singlet at δ 
4.83 due to the existence of a mirror plane as detailed in 
Scheme 3. 
NN
Ir O
excess 
py, H2, 
CD2Cl2 NN
Ir
OH
H
py
py
NN
Ir OH
H
py
py
py
CD3OD
255 K
1
6
3
pyridine
H2
243 K
265 K
NN
Ir
O
H H
2
4 5
298 K
CD2Cl2
/ C6D6
243 K
NN
Ir Opy
NN
Ir
O
H H
py
 
Scheme 3. Species formed during the reaction of 1 with H2 and pyridine in CD3OD (4, 5 
and 6) and CD2Cl2 or C6D6 (2 and 3) solution. 
 Complex 6 is zwitterionic, and its cationic Ir(III) centre is 
balanced by phenoxide ion formation. Hence the final reaction 
product formed from 1 with pyridine and H2 is solvent 
dependent. The two pyridine ligands of 6 that lie trans to 
hydride are shown to dissociate with an experimental rate 
constant of 1.35 ± 0.03 s
−1
 at 294 K, although no exchange of 
the pyridine trans to the carbene is observed. In CD3OD, rapid 
H/D exchange, accompanied by HD formation, is observed 
which prevents the quantification of the H2 loss rate in this 
solvent. At 294 K, the ligand exchange rates of species 3 in 
C6D6 are therefore much faster than those in CD2Cl2, but both 
are faster than those of 6 in CD3OD as shown in the ESI. 
 The ligand exchange rates of 6 in CD3OH were examined as 
a function of temperature and activation parameters for these 
processes were calculated (see ESI). The activation enthalpy 
values for both pyridine and hydride loss are very similar to 
each other (90.7 ± 1.6 kJ mol
−1
 and 88.3 ± 9.1 kJ mol
−1
 
respectively). The entropy of activation values of 71.3 ± 5.3 J 
K
−1
 and 56.1 ± 30.6 J K
−1
 for pyridine and hydride loss 
respectively are also similar and positive thereby confirming 
the dissociative character of these steps.
7
 Similar ligand 
exchange processes, in a series of related complexes, yield 
values of similar size.
7,32
 A ligand exchange mechanism 
featuring reversible pyridine dissociation with H2 loss via 
[Ir(κC,O
−
-L1)(H)2(H2)(py)2]
+
 is therefore indicated.
33
 
 Both catalysts 3 and 6 therefore exhibit the substrate and 
H2 exchange characteristics required for them to act as SABRE 
catalysts. To test their substrate signal enhancing 
performance, samples were prepared containing catalyst 1 and 
a chosen substrate in the desired NMR solvent. These were 
rigorously degassed before the addition of 3 bars of H2. 
Samples were tested by reintroducing p-H2 into the headspace 
of the NMR tube, shaking the sample in the low field outside of 
the spectrometer and then rapidly transferring the sample into 
the spectrometer for examination. This resulted in the 
observation of enhanced signals in the corresponding single 
scan 
1
H NMR spectra for the hydride ligands, bound substrate 
and free substrate in solution as exemplified by Figure 2. The 
total enhancement value seen for the five protons of pyridine 
in C6D6 proved to be 1850-fold under the conditions detailed. 
For CD2Cl2 this enhancement level was reduced to ca. 1660-
fold whilst for CD3OD solution it became 710-fold. Given the 
corresponding gain in signal-to-noise levels that these 
enhancements provide, the resulting time savings are 
substantial in all solvents. For comparison purposes, the site 
specific enhancement values for the substrates pyridine, 
nicotinaldehyde and nicotine are summarised in Table 1. The 
performance of 1 as a SABRE catalyst for pyridine like 
substrates has therefore been established. 
 
Figure 2. Thermally polarised and hyperpolarised 
1
H NMR spectra of a CD2Cl2 solution 
containing 0.06 M pyridine, 11 mol% 1 and 3 bars p-H2. The enhanced signals for free 
and bound pyridine (in 3) and the corresponding hydride ligands are indicated. 
Table 1. Maximum 
1
H NMR SABRE enhancements (fold) observed for solutions 
containing pyridine (0.06 M and 11 mol% 1), nicotinaldehyde(0.05 M and 14 mol% 1) 
and nicotine (0.04 M and 16 mol% 1) in CD2Cl2, C6D6 and CD3OD under 3 bars p-H2. 
 Pyridine 
1
H NMR SABRE enhancement (fold) 
Solvent ortho meta para 
C6D6 843 ± 27 600 ± 30 404 ± 13 
CD2Cl2 877 ± 32 337 ± 57 450 ± 22 
CD3OD 426 ± 5 47 ± 28 243 ± 3 
 Nicotinaldehyde 
1
H NMR SABRE enhancement (fold) 
Solvent HA HB HC HD 
C6D6 259 ± 17 209 ± 22 118 ± 22 244 ± 18 
CD2Cl2 486 ± 36 400 ± 32 148 ± 34 396 ± 65 
CD3OD 62 ± 7 59 ± 10 26 ± 7 65 ± 6 
 Nicotine 
1
H NMR SABRE enhancement (fold) 
Solvent HA HB HC HD 
C6D6 400 ± 54 315 ± 48 88 ± 30 338 ± 80 
CD2Cl2 419 ± 51 381 ± 48 146 ± 44 386 ± 55 
CD3OD 29 ± 4 28 ± 3 3 ± 3 31 ± 3 
 
  It is known that the amount of signal enhancement 
observed in the 
1
H NMR spectrum of a substrate under SABRE 
is significantly affected by the ligand exchange rates, as 
previously explained by Green et al.
34
 For comparison, 
[Ir(H)2(IMes)(py)3]Cl, is commonly used as the catalyst 
benchmark for SABRE and its pyridine dissociation rate
32
 was 
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found to be 23 s
−1
. While the ligand dissociation rates for 3 and 
6 are much lower, they still achieve good hyperpolarisation 
levels. In fact, these data show that one pyridine substrate 
trans to hydride in CD2Cl2 or C6D6 is more efficient at receiving 
SABRE than the two equivalent pyridine ligands of 6 in CD3OD. 
Furthermore, the concept of an active solvent responsive 
catalyst is illustrated. 
 In summary, the iridium precatalyst Ir(κC,O-L1)(COD), 1 
containing a phenolate substituted NHC has been synthesised 
and shown to act as an efficient SABRE catalyst precursor. The 
active catalytic species is solvent dependent. Complex 1 
contains an Ir-O bond which is affected by solvent polarity and 
proton availability; in non-polar C6D6 and polar aprotic CD2Cl2, 
this bond is strong and substitution resistant with 1 forming 
Ir(κC,O-L1)(H)2(py)2 (3) on reaction with H2 and pyridine. In 
contrast, on changing to polar protic methanol, the Ir-O bond 
becomes labile and the phenolate easily dissociates from the 
iridium centre, such that zwitterionic [Ir(κC,O
−
-L1)(H)2(py)3]
+
 (6) 
forms. 6 is directly analogous to the efficient SABRE catalyst 
[Ir(H)2(IMes)(py)3]Cl which performs well in CD3OD but has 
lower activity in non-polar CD2Cl2 and C6D6. Both 3 and 6 
undergo pyridine and H2 exchange thereby enabling them to 
act as SABRE catalysts. Whilst 6 works well in CD3OD, catalyst 
neutrality in the non-polar solvents CD2Cl2 and C6D6 results in 
the formation of 3 which is highly active for SABRE catalysis. 
This study therefore shows that catalyst design and control can 
lead to improved magnetisation transfer in a range of solvents, 
a requirement for future studies that seek to identify low 
concentration analytes
35-37
 and to produce hyperpolarised MRI 
contrast agents. 
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